Breaking news

Isomorphic Labs Secures $600 Million To Revolutionize Drug Discovery With AI

by THEFUTURE.TEAM

April 7, 2025

Isomorphic Labs, the trailblazing AI-driven drug discovery startup, has successfully raised $600 million in its inaugural funding round. The Series A round, spearheaded by Thrive Capital, also saw continued backing from Alphabet’s Google Ventures, marking a significant milestone for the company.

Why This Matters

With AI rapidly becoming the core of innovation in nearly every tech sector, Isomorphic Labs is tapping into the booming intersection of artificial intelligence and pharmaceuticals. As demand for AI-powered solutions surges, particularly in drug development, this latest investment highlights the growing importance of AI in reshaping the life sciences industry.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The Backstory

Founded in 2021, Isomorphic Labs emerged from Google’s renowned AI research division, DeepMind. The company builds on DeepMind’s groundbreaking advancements, including the Nobel-winning “AlphaFold” model, which accurately predicts protein structures—critical to understanding diseases and developing new drugs. Isomorphic’s work represents the next frontier in AI-powered medicine.

Looking Ahead

The newly secured capital will fuel the company’s R&D ambitions and accelerate its talent acquisition. Founder and CEO Demis Hassabis, who also heads DeepMind, has ambitious plans. He aims for Isomorphic Labs to have AI-designed drugs entering clinical trials by the end of 2025—a timeline that underscores both the company’s potential and the immense promise of AI in revolutionizing drug discovery.

This $600 million funding round not only signals strong investor confidence but also cements Isomorphic Labs’ position at the forefront of the AI pharmaceutical revolution.

The Future Forbes Realty Global Properties

Sklavenitis Cyprus Sets A New Standard For Employee-Centric Benefits

by THEFUTURE.TEAM

September 12, 2025

Investing In Human Capital

In a bold move that underscores the growing importance of human capital in today’s business landscape, Sklavenitis Cyprus has taken innovative steps to ensure its workforce is both valued and supported. The supermarket chain has introduced a policy to pay a 14th salary to all employees—including those from Papantoniou Supermarkets—cementing its status as the sole retailer in Cyprus to implement such a comprehensive benefit.

A Significant Investment In People

This initiative is far from symbolic. With an estimated total cost of €2 million, it represents a committed investment in the company’s most valuable asset—its people. By providing an additional salary, Sklavenitis reinforces a culture of inclusivity and fairness, acknowledging every employee’s contribution to its success.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Robust Benefits For Long-Term Stability

Complementary to the 14th salary, the company has launched a robust benefits program designed to address both financial and personal security. An Automatic Cost of Living Adjustment (ATA) of 12.56 per cent ensures that wages remain aligned with inflation, safeguarding real income stability for its team members.

Comprehensive Health And Life Support

Sklavenitis further enhances employee welfare through access to a Group Life and Health Insurance Plan and a Provident Fund co-funded by the employer. These measures not only provide immediate protection but also empower employees to plan confidently for the future.

Exclusive Perks And Incentives

The company extends its commitment beyond conventional benefits by offering store discounts, a birth allowance, and holiday gift vouchers valued at €100 during both Easter and Christmas. These additional perks enhance employee satisfaction and underline Sklavenitis’ people-first ethos.

A Strategy For Mutual Success

In an industry where employee engagement directly impacts customer satisfaction, Sklavenitis’ comprehensive approach stands out as both a progressive and strategic business decision. By investing in its workforce, the company not only nurtures a supportive workplace but also drives superior corporate performance, setting a new benchmark for responsible employment practices in Cyprus.